SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-036398
Filing Date
2021-03-15
Accepted
2021-03-15 17:21:11
Documents
7
Period of Report
2021-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm219662d1_8k.htm 8-K 25845
2 EXHIBIT 1.1 tm219662d1_ex1-1.htm EX-1.1 223332
3 EXHIBIT 5.1 tm219662d1_ex5-1.htm EX-5.1 14192
4 EXHIBIT 99.1 tm219662d1_ex99-1.htm EX-99.1 14753
5 GRAPHIC image_002.jpg GRAPHIC 3439
6 GRAPHIC image_003.jpg GRAPHIC 2437
7 GRAPHIC image_004.jpg GRAPHIC 2970
  Complete submission text file 0001104659-21-036398.txt   292002
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 21742560
SIC: 2834 Pharmaceutical Preparations